when a deadly fungus became medicine—and changed history

The Contaminated Petri Dish That Changed Medicine

Alexander Fleming returned to his St. Mary's Hospital laboratory in London on September 3, 1928, after vacationing in Scotland with his family. The 47-year-old bacteriologist had left several petri dishes containing Staphylococcus aureus cultures stacked by an open window, unrefrigerated and exposed to the air. One dish now displayed an unusual sight: a blue-green mold colony surrounded by a clear halo where bacterial growth had completely ceased. Fleming showed the contaminated plate to his assistant, Frederick Ridley, remarking that it looked interesting enough to investigate rather than discard.

The mold was identified as Penicillium notatum, later reclassified as Penicillium chrysogenum, a species commonly found on bread and citrus fruits. Fleming's colleague Charles La Touche, a mycologist working one floor below, had been studying Penicillium strains for research on asthma triggers, and spores had likely drifted upward through the building's ventilation system. Fleming cultured the mold in broth and found that even diluted 800 times, the liquid still killed various bacteria. He named the antibacterial substance "penicillin" and published his findings in the British Journal of Experimental Pathology in 1929, though the paper initially attracted minimal attention from the medical community.

From Laboratory Curiosity to Mass-Produced Medicine

Fleming lacked the chemical expertise to isolate and purify penicillin in sufficient quantities for human trials, and his initial attempts to concentrate the compound failed because it proved remarkably unstable. The substance lost potency within days at room temperature, and Fleming's crude filtrates contained numerous impurities that caused adverse reactions when tested on rabbits. After several frustrating years, he largely abandoned therapeutic research on penicillin by 1935, though he continued providing samples to other scientists. His discovery remained a laboratory oddity for over a decade, mentioned occasionally in academic papers but considered impractical for clinical medicine.

The breakthrough came in 1939 when Oxford University pathologist Howard Florey and biochemist Ernst Boris Chain began systematically studying antibacterial substances. Working with Norman Heatley, who designed innovative extraction equipment, they developed freeze-drying techniques that preserved penicillin's potency and achieved purification levels sufficient for animal testing. By May 1940, their team had accumulated enough penicillin to inject eight mice with lethal doses of Streptococcus bacteria; four received penicillin treatment and survived, while the four untreated controls died within hours. On February 12, 1941, they administered penicillin to Albert Alexander, a 43-year-old Oxford policeman dying from a facial infection that had spread to his lungs and skull. Alexander improved dramatically within 24 hours, but the limited supply ran out after five days, and he relapsed fatally, demonstrating both penicillin's extraordinary effectiveness and the critical need for industrial-scale production.

The Accidental Convergence Nobody Predicted

Fleming's discovery depended on an improbable chain of coincidences that historians later calculated had odds of roughly one in ten million. The specific Penicillium strain that contaminated his plate was unusually potent compared to other varieties, and it happened to land on a culture of Staphylococcus, one of the few bacterial species highly susceptible to penicillin's effects. London experienced an unseasonable cold snap during Fleming's absence in August 1928, with temperatures dropping to 65°F, which allowed the mold to establish itself before warmer weather returned and accelerated bacterial growth. Had the temperature remained consistently warm, the faster-growing bacteria would have overgrown the slower mold before it produced detectable penicillin.

Fleming himself was notably untidy, and colleagues frequently joked about his cluttered workbench covered with unwashed glassware and abandoned experiments. Almroth Wright, director of St. Mary's Inoculation Department, had previously reprimanded Fleming for his messy habits, but this very carelessness created the conditions for his greatest discovery. Ronald Hare, who later occupied Fleming's old laboratory, attempted to recreate the contamination scenario in 1966 and found it nearly impossible to reproduce the original combination of environmental factors. Fleming acknowledged the role of chance in a 1945 interview with The Times, stating: "I did not invent penicillin. Nature did that. I only discovered it by accident."

Why Penicillin Remains Medicine's Most Significant Discovery

Penicillin became the first mass-produced antibiotic during World War II, with American pharmaceutical companies producing 2.3 million doses in time for the D-Day invasion in June 1944. Military surgeons reported infection mortality rates dropping from 18 percent in World War I to less than 1 percent by 1945, saving an estimated 12 to 15 percent of Allied lives that would have otherwise been lost to battlefield wound infections. The Cocoanut Grove nightclub fire in Boston on November 28, 1942, which killed 492 people, became penicillin's first major civilian test when doctors treated survivors with the still-experimental drug, dramatically reducing deaths from burn infections and demonstrating its potential beyond military applications.

The World Health Organization estimates that penicillin and its derivatives have saved over 200 million lives since 1942, making it arguably the most important medical discovery of the twentieth century. Fleming, Florey, and Chain shared the 1945 Nobel Prize in Physiology or Medicine, though bitter disputes over credit persisted for decades, with Fleming receiving disproportionate public acclaim despite Florey and Chain's essential contributions to making penicillin therapeutically viable. Today, penicillin-based antibiotics remain first-line treatments for streptococcal infections, syphilis, and numerous other bacterial diseases, though antibiotic resistance—which Fleming himself warned about in his 1945 Nobel lecture—now threatens to undermine penicillin's effectiveness, with resistant Staphylococcus aureus strains killing approximately 20,000 Americans annually according to CDC estimates from 2019.